FIELD: medicine.
SUBSTANCE: invention refers to medicine and veterinary science, and is intended for treating herpes virus diseases. A lyophilised preparation of allofibroblasts is used as an antiviral agent.
EFFECT: invention is effective for treating herpes virus of human and vertebrate animals.
6 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
4,6-DI(3,12-DIAZA-6,9-DIAZONIADISPIRO[5,2,5,2]HEXADECAN-1-YL)-2-METHYL-5-NITROPYRIMIDINE TETRACHLORIDE HYDROCHLORIDE HEXAHYDARATE FOR TREATING HERPETIC INFECTION, PHARMACEUTICAL COMPOSITION FOR LOCAL APPLICATION | 2014 |
|
RU2573977C9 |
ANTIVIRAL GEL AS GEL BASED ON HUMAN LEUKOCYTE INTERFERON | 2005 |
|
RU2302881C2 |
METHOD FOR TREATING UROGENITAL INFECTIONS | 1999 |
|
RU2160604C1 |
METHOD OF TREATMENT FOR GENITAL HERPES | 2007 |
|
RU2339377C1 |
AGENT POSSESSING BIOCIDAL ACTION | 2017 |
|
RU2673807C2 |
ANTIVIRAL PREPARATION | 1994 |
|
RU2071323C1 |
METHOD FOR TREATING ACUTE HEPRETIC STOMATITIS IN CHILDREN | 2011 |
|
RU2444372C1 |
METHOD OF INCREASING CLINICAL IMMUNE EFFICIENCY OF GENITAL HERPES THERAPY USING INTRAVASCULAR BLOOD LASER EXPOSURE | 2015 |
|
RU2602304C1 |
PHARMACEUTICAL COMPOSITION FOR HERPES TREATMENT | 1998 |
|
RU2165264C2 |
METHOD OF POTENTIATION OF MEDICINAL AGENT CURATIVE EFFECT | 1997 |
|
RU2104032C1 |
Authors
Dates
2013-06-10—Published
2012-01-26—Filed